Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlo Confalonieri"'
Publikováno v:
Breast Cancer Research and Treatment. 87:233-243
Background. Since most advanced cancers are still incurable, oncologic clinical research pays considerable attention to palliation, increasingly valuing subjective measures of outcome such as quality of life (QoL). We reviewed randomised clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd59107c1cd82feab574211043a5dcd
https://doi.org/10.1007/s10549-004-8694-y
https://doi.org/10.1007/s10549-004-8694-y
Autor:
Giovanni Apolone, Roberto Grilli, Alexan A. Alexanian, Carlo Confalonieri, Roberto Labianca, Paola Liati, Silvia Marsoni, Giancarlo Martignoni, Paola Mosconi, Antonio Nicolucci, Gian Franco Pancera, Anna Taiana, Walter Torri, Alberto Zaniboni, Alessandro Liberati
Publikováno v:
Scopus-Elsevier
Over the last ten years the Italian National Research Council (C.N.R.) has launched an educational program aimed at favoring the delivery of the most up to date care for cancer patients in community hospitals. Among various tumors for which this effo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f608fd41dc1666dfb4c3aa8299fe17
https://pubmed.ncbi.nlm.nih.gov/2368171
https://pubmed.ncbi.nlm.nih.gov/2368171
Publikováno v:
Breast Cancer Research & Treatment; Oct2004, Vol. 87 Issue 3, p233-243, 11p
Autor:
Marcello Tamburini, Paola Viola, Gianni Tognoni, Alessandro Liberati, Gemma Martino, Renato Talamini, Carlo Confalonieri
Publikováno v:
Tumori. 71(5)
Patients’ assessment of quality of care was investigated in 825 women with breast cancer treated in a group of specialized and non-specialized institutions in Italy. A 10-page mail questionnaire explored patients’ adjustment to the disease, satis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492cefa22762584aba2bb02456a3cd0f
https://pubmed.ncbi.nlm.nih.gov/4060250
https://pubmed.ncbi.nlm.nih.gov/4060250
Autor:
Carlo Confalonieri, Luciano Scandolaro, Mozzana R, Enrico Pogliani, Franco Lombardi, Pietro Pioltelli, Paolo Vanoli, E Cassi, Luca Baldini, A Tosi, Chiara Butti, Luigi Montalbetti, Gaetano Brambilla Pisoni, Anna Ceriani, Giorgio Lambertenghi-Deliliers, Gianfranco Pavia, Alberto De Paoli, Graziella Pinotti
Publikováno v:
Europe PubMed Central
Chemotherapy using cyclophosphamide, doxorubicin, etoposide, cytarabine, bleomycin, vincristine, methotrexate with leucovorin, and prednisone (ProMACE-CytaBOM) for patients with intermediate or high grade non-Hodgkin lymphomas (G, H and K according t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d21aca5ed144df2f8c4d1efd3851ccb3
http://europepmc.org/abstract/med/7517742
http://europepmc.org/abstract/med/7517742
Autor:
Roberto Grilli, Alexan A. Alexanian, Giovanni Apolone, Carlo Confalonieri, Roldano Fossati, Paola Liati, Maria Cristina Liberati, Silvia Marsoni, Paola Mosconi, Nicoletta Monferroni, Antonio Nicolucci, Anna Taiana, Valter Torri, Paolo Zola, Alessandro Liberati
Publikováno v:
Scopus-Elsevier
We reviewed care delivered to about 2,500 breast cancer patients in general hospitals over the period 1979-1987 using data from three surveys. The most important and consistent failure was in diagnostic timeliness: about one out of four patients was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f80646a3b9a09d31f5c0de06133c0e
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025213915&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025213915&partnerID=MN8TOARS